-
Omeprazole (Prilosec) approved for OTC heartburn treatment; Recall includes all repacked atorvastatin products; Paroxetine (Paxil) should not be used in children; FDA announces pilot program to post warning letter responses
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
In other legislation favorable to pharmacists, the Senate Committee on Health, Education, Labor, and Pensions recently passed a bipartisan bill that would provide two student loan repayment programs for certain pharmacists. The bill now moves on to the Senate floor for consideration.
-
Almotriptan malate (Axert) a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, otherwise known as a triptan, was approved by the U.S. Food and Drug Administration (FDA) in May 2001.
-
In the Pipeline
-
New hospital technology is helping to move health care systems away from the centralized dispensing pharmacy model to a more integrated pharmacy practice model, according to results from the 2009 American Society of Health-System Pharmacists (ASHP) National Survey.
-
Expense-based budgeting is traditional; it's comfortable, and it's no longer top of the evolving hospital pharmacy's radar screen.
-
Research shows that 60% to 80% of intensive care unit (ICU) patients experience delirium, making this a significant diagnosis in this population.
-
The American Society of Health-System Pharmacists (ASHP) of Bethesda, MD, and the Institute for Safe Medication Practices (ISMP) of Horsham, PA, launched in mid-December, 2009, a new national alert system to prevent medication errors. It' called the National Alert Network for Serious Medication Errors (NAN).
-
The 2009 American Society of Health-System Pharmacists (ASHP) National Survey highlights the escalating trend of hospital pharmacists becoming more involved in clinical care.
